Aimedis is a medical care platform. It works as an intermediary between doctors and patients in order to create a medical data marketplace, where users can provide medical data to the doctors, and doctors can diagnose patients. At Aimedis, online medical prescriptions are possible as well as access to A.I. (Artificial Intelligence) tools that are able to examine medical data.

The Aimedis (AIM) token is an Ethereum-based (ERC-20) cryptocurrency. It will serve the users as a medium to exchange value between them and/or to pay for other users medical services when using Aimedis. In addition, to buy or sell medical data, AIM tokens are required.

Team:

• Dr. Michael J. Kaldasch: CEO, MD & founder. 
• Dr. Ben El Idrissi: COO, MD & founder. 
• Sankar Ghanesh: CTO. 
• Dr. Lazaros Fountoukidis: CMO & MD. 

Aimedis ICO will begin on TBA. The ICO token supply represents 50% of the total token supply, so there is a total of 300,000,000 AIM tokens available, for 0.12 USD each. The ICO funding target is 9,000,000 USD, the funding cap is 36,000,000 USD and is expected to end on TBA or when the funding cap is reached.

Token Reserve Split (50%):

• 20% Community initiatives, marketing & legal;
• 20% Team, supporters & advisory board;
• 5% Legal reserve;
• 5% Reserve.

Aimedis ICO features a bonus of 20% upon the Pre-Sale.